Pharma companies look pale today. Know why
Advertisement
Advertisement
Pharma giant Lupin Ltd. was the top loser on the Lupin reported its first quarter consolidated Net Profit fell to 525 crore rupees versus 625 crore rupees in the same period a year ago. Similarly, the April-to-June period saw Lupin's sales dip to `3,070 crores compared with 3,284 rupees in the same period a year ago.
The market was expecting a PAT of 580 crores on sales of 3,345 crore rupees.
Lupin's stock, meanwhile, dropped 5.5 percent, or 95 rupees, to 1,729 rupees on the National Stock Exchange with 42 lakh shares changing hands on the exchange.
Sentiment has weakened on pharma companies after Sun Pharma gave a profit warning two days ago, post its merger with Ranbaxy.
Advertisement
(Image credit: Indiatimes)
Advertisement
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- A centenarian who starts her day with gentle exercise and loves walks shares 5 longevity tips, including staying single
- 2 states where home prices are falling because there are too many houses and not enough buyers
- "To sit and talk in the box...!" Kohli's message to critics as RCB wrecks GT in IPL Match 45
- 7 Nutritious and flavourful tiffin ideas to pack for school
- India's e-commerce market set to skyrocket as the country's digital economy surges to USD 1 Trillion by 2030
- Top 5 places to visit near Rishikesh
- Indian economy remains in bright spot: Ministry of Finance